Antiviral monoclonal antibody cocktails as a modern weapon in combating pandemics

References

• 1. Antibody Society, COVID-19 biologics tracker (2021). https://www.antibodysociety.org/covid-19-biologics-tracker/
  Google Scholar
• 2. FDA. Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibody for Treatment of COVID-19 (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibody-treatment-covid-19
  Google Scholar
• 3. Wang P, Nair M, Liu L et al. Antibody resistance of SARS-CoV-2 variants B. 1.351 and B. 1.1. 7. Nature 593(7857), 130–135 (2021).
  Medline CASGoogle Scholar
• 4. Brennan Z. US to no longer distribute Eli Lilly’s bamlanivimab alone due to coronavirus variants (2021). https://endpts.com/us-to-no-longer-distribute-eli-lillys-bamlanivimab-alone-due-to-coronavirus-variants/
  Google Scholar
• 5. FDA. Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19(2021). http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19
  Google Scholar
• 6. FDA. Fact Sheet For Health Care Providers Emergency Use Authorization (EUA) Of REGEN-COV^TM (casirivimab and imdevimab)(2021). https://www.fda.gov/media/145611/download
  Google Scholar
• 7. Sitlani A, Malhotra S, Aggarwal P et al. Monoclonal Antibodies For COVID-19 Are A Potentially Life-Saving Therapy: How Can We Make Them More Accessible? Health Affairs (2021). https://www.healthaffairs.org/do/10.1377/hblog20210901.667955/full/
  Google Scholar
• 8. FDA. Fact Sheet For Healthcare Providers Emergency Use Authorization (EUA) Of Sotrovimab (2021). https://www.fda.gov/media/149534/download
  Google Scholar
• 9. FDA. Fact Sheet For Health Care Providers Emergency Use Authorization (EUA) Of Bamlanivimab And Etesevimab (2021). https://www.fda.gov/media/145802/download
  Google Scholar
• 10. Luo L, Jiang B, Cao Y et al. A hydrophobic interaction chromatography method suitable for quantitating individual monoclonal antibodies contained in co-formulated drug products. Journalof Pharmaceutical and Biomedical Analysis 193, 113703 (2021).
  Medline CASGoogle Scholar
• 11. Chauhan V, Zhan H, Dalby P et al. Advancements in the co-formulation of biologic therapeutics. Journal of Controlled Release 327, 397–405(2020).
  Medline CASGoogle Scholar
• 12. Rainwater-Lovett K, Redd J, Stewart M et al. Real-world Effect of Monoclonal Antibody Treatment in COVID-19 Patients in a Diverse Population in the United States. Open Forum Infectious Diseases 8(8), (2021). https://doi.org/10.1093/ofid/ofab398
  MedlineGoogle Scholar